Healthcare Sector and Stocks Analysis from Seeking Alpha
Sat, 4 Aug 2012
By Vytautas Drumelis : Vivus, Inc. ( VVUS ) is scheduled to report its Q2 2012 results on August 7, 2012, after the bell. The Street expects EPS of ($0.23) loss. In this article, I will recap the historical results of the company, its latest EPS estimates vs. surprises, the latest news from VVUS ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.